Home › Funds › Point72 Asset Management › ENGN
Point72 Asset Management position in ENGN
ENGENE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)13.99K sh
Reported value held$24.21K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 182.59K | $3.09M | New |
| Q2 2024 | 43.90K | $413.98K | Reduce |
| Q3 2024 | 663.00K | $4.38M | Add |
| Q4 2024 | 1.22M | $8.14M | Add |
| Q1 2025 | 1.24M | $5.56M | Add |
| Q1 2025 | 1.24M | $5.56M | Add |
| Q2 2025 | 1.21M | $4.40M | Reduce |
| Q2 2025 | 1.21M | $4.40M | Reduce |
| Q3 2025 | 1.21M | $8.25M | Hold |
| Q4 2025 | 561.80K | $5.07M | Reduce |
| Q1 2026 | 173.39K | $1.18M | Reduce |
| Q2 2026 | 13.99K | $24.21K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENGN
- Balyasny Asset Management 1.01M sh · $1.74M · Q2 2026
- Renaissance Technologies 829.70K sh · $1.44M · Q2 2026
- UBS Group AG 509.09K sh · $880.72K · Q2 2026
- Two Sigma Investments 164.57K sh · $284.71K · Q2 2026
- Morgan Stanley 33.09K sh · $57.24K · Q2 2026
- Citadel Advisors 30.80K sh · $53.28K · Q2 2026
- D. E. Shaw & Co 104.62K sh · $30.33K · Q2 2026
- Millennium Management 69.00K sh · $20.00K · Q2 2026
- Wells Fargo & Co 6.84K sh · $11.83K · Q2 2026